Login to Your Account


Combined Firm Adds £15M

'One-Stop Shop' RNAi Delivery Firm; Silence, Intradigm Merge

By Jennifer Boggs


Thursday, December 17, 2009
UK-listed Silence Therapeutics plc and privately held Intradigm Corp. agreed to a merger deal that could give the combined firm a competitive edge in the RNAi landscape currently dominated by firms such as Alnylam Pharmaceuticals Inc. and Sirna Therapeutics Inc. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription


»

BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Privacy Policy | Terms of Use
 
Part of Thompson Media Group LLC

Free Ezine

Sign up for Perspectives FREE e-mail newsletter.

Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.